204 related articles for article (PubMed ID: 33457076)
21. Plac1 Remodels the Tumor Immune Evasion Microenvironment and Predicts Therapeutic Response in Head and Neck Squamous Cell Carcinoma.
Meng X; Liu Z; Zhang L; He Y
Front Oncol; 2022; 12():919436. PubMed ID: 35814442
[TBL] [Abstract][Full Text] [Related]
22. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.
Kobayashi H; Lu J; Celis E
Cancer Res; 2001 Oct; 61(20):7577-84. PubMed ID: 11606397
[TBL] [Abstract][Full Text] [Related]
23. PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer.
Li Q; Liu M; Wu M; Zhou X; Wang S; Hu Y; Wang Y; He Y; Zeng X; Chen J; Liu Q; Xiao D; Hu X; Liu W
Oncol Lett; 2018 Apr; 15(4):5924-5932. PubMed ID: 29556312
[TBL] [Abstract][Full Text] [Related]
24. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
25. p53 as an immunotherapeutic target in head and neck cancer.
Hoffmann TK; Bier H; Donnenberg AD; Whiteside TL; De Leo AB
Adv Otorhinolaryngol; 2005; 62():151-60. PubMed ID: 15608425
[TBL] [Abstract][Full Text] [Related]
26. Immunization with placenta-specific 1 (plac1) induces potent anti-tumor responses and prolongs survival in a mouse model of melanoma.
Rahdan S; Razavi SA; Shojaeian S; Shokri F; Amiri MM; Zarnani AH
Adv Med Sci; 2022 Sep; 67(2):338-345. PubMed ID: 36084365
[TBL] [Abstract][Full Text] [Related]
27. Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles.
Kobayashi H; Song Y; Hoon DS; Appella E; Celis E
Cancer Res; 2001 Jun; 61(12):4773-8. PubMed ID: 11406551
[TBL] [Abstract][Full Text] [Related]
28. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
29. Establishment of HLA-DR4 transgenic mice for the identification of CD4+ T cell epitopes of tumor-associated antigens.
Yatsuda J; Irie A; Harada K; Michibata Y; Tsukamoto H; Senju S; Tomita Y; Yuno A; Hirayama M; Abu Sayem M; Takeda N; Shibuya I; Sogo S; Fujiki F; Sugiyama H; Eto M; Nishimura Y
PLoS One; 2013; 8(12):e84908. PubMed ID: 24386437
[TBL] [Abstract][Full Text] [Related]
30. Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients.
Dong XY; Peng JR; Ye YJ; Chen HS; Zhang LJ; Pang XW; Li Y; Zhang Y; Wang S; Fant ME; Yin YH; Chen WF
Int J Cancer; 2008 May; 122(9):2038-43. PubMed ID: 18183594
[TBL] [Abstract][Full Text] [Related]
31. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
32. Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.
Sato N; Nabeta Y; Kondo H; Sahara H; Hirohashi Y; Kashiwagi K; Kanaseki T; Sato Y; Rong S; Hirai I; Kamiguchi K; Tamura Y; Matsuura A; Takahashi S; Torigoe T; Ikeda H
Cancer Chemother Pharmacol; 2000; 46 Suppl():S86-90. PubMed ID: 10950155
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
[TBL] [Abstract][Full Text] [Related]
34. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
35. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.
Zarour HM; Maillere B; Brusic V; Coval K; Williams E; Pouvelle-Moratille S; Castelli F; Land S; Bennouna J; Logan T; Kirkwood JM
Cancer Res; 2002 Jan; 62(1):213-8. PubMed ID: 11782380
[TBL] [Abstract][Full Text] [Related]
36. Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.
Cillo AR; Kürten CHL; Tabib T; Qi Z; Onkar S; Wang T; Liu A; Duvvuri U; Kim S; Soose RJ; Oesterreich S; Chen W; Lafyatis R; Bruno TC; Ferris RL; Vignali DAA
Immunity; 2020 Jan; 52(1):183-199.e9. PubMed ID: 31924475
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes.
Fujiki F; Oka Y; Tsuboi A; Kawakami M; Kawakatsu M; Nakajima H; Elisseeva OA; Harada Y; Ito K; Li Z; Tatsumi N; Sakaguchi N; Fujioka T; Masuda T; Yasukawa M; Udaka K; Kawase I; Oji Y; Sugiyama H
J Immunother; 2007 Apr; 30(3):282-93. PubMed ID: 17414319
[TBL] [Abstract][Full Text] [Related]
38. Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.
Ohara K; Ohkuri T; Kumai T; Nagato T; Nozaki Y; Ishibashi K; Kosaka A; Nagata M; Harabuchi S; Ohara M; Oikawa K; Aoki N; Harabuchi Y; Celis E; Kobayashi H
Oncoimmunology; 2018; 7(9):e1466771. PubMed ID: 30510853
[TBL] [Abstract][Full Text] [Related]
39. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
[TBL] [Abstract][Full Text] [Related]
40. Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma.
Kumai T; Ohkuri T; Nagato T; Matsuda Y; Oikawa K; Aoki N; Kimura S; Celis E; Harabuchi Y; Kobayashi H
Sci Rep; 2015 Nov; 5():16280. PubMed ID: 26538233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
